<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">7R6ZmC4pKyXG7d3VRySQyCh</article-id>
      <article-id pub-id-type="other">00004</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2009000700004</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(09)09300104</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2009000700004</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Doen&#231;a arterial coronariana subcl&#237;nica em pacientes com Diabetes Mellitus tipo 1 em hemodi&#225;lise</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Oliveira</surname>
            <given-names>Dinaldo Cavalcanti de</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brito Junior</surname>
            <given-names>Fabio Sandoli de</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fernandes</surname>
            <given-names>Rosley Weber Alvarenga</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sa</surname>
            <given-names>Jo&#227;o Roberto de</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lima</surname>
            <given-names>Valter Correia de</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <institution content-type="orgname">Funda&#231;&#227;o Oswaldo Ramos</institution>
        <institution content-type="orgdiv1">Hospital do Rim e Hipertens&#227;o </institution>
      </aff>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">Hospital S&#227;o Paulo </institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>07</month>
        <year>2009</year>
      </pub-date>
      <volume>93</volume>
      <issue>1</issue>
      <fpage>15</fpage>
      <lpage>21</lpage>
      <history>
        <date date-type="rev-recd">
          <day>19</day>
          <month>06</month>
          <year>2008</year>
        </date>
        <date date-type="received">
          <day>26</day>
          <month>01</month>
          <year>2008</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>06</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: A aterosclerose ocorre mais cedo em pacientes com diabetes mellitus tipo 1 (DM-1) e a doen&#231;a arterial coronariana (DAC) constitui a mais importante causa de morte. OBJETIVO: Avaliar a preval&#234;ncia e as caracter&#237;sticas anat&#244;micas da DAC em pacientes com DM-1 e insufici&#234;ncia renal cr&#244;nica, submetidos &#224; di&#225;lise. M&#201;TODOS: Este &#233; um estudo descritivo de 20 pacientes com DM-1 submetidos &#224; di&#225;lise sem DAC conhecida. A DAC foi avaliada atrav&#233;s de angiografia coronariana quantitativa (ACQ) e ultra-som intravascular (USIV). A ACQ foi realizada em todas as les&#245;es &gt;30%, visualmente Todos os segmentos proximais de 18 mm das art&#233;rias coron&#225;rias foram analisados por USIV. Todos os outros segmentos coronarianos com estenose &gt;30% tamb&#233;m foram analisados. RESULTADOS: A angiografia detectou 29 les&#245;es &gt;30% em 15 pacientes (75%). Onze (55%) das les&#245;es eram &gt;50% e 10 (50%) &gt;70%. Treze pacientes tiveram as 3 principais art&#233;rias avaliadas pelo USIV. A aterosclerose estava presente em todos os pacientes e em todos os 51 segmentos proximais de 18 mm analisados. Esses segmentos significam que a medida do di&#226;metro dos vasos apresentava-se significantemente maior no USIV do que na ACQ, em todos os vasos. As imagens do ISIV de 25 (86,2%) das 29 les&#245;es &gt;30% foram obtidas. Placas fibr&#243;ticas eram comuns (48%) e 60% apresentavam remodelamento intermedi&#225;rio de vasos. CONCLUS&#195;O: A DAC estava presente em todos os vasos de todos os pacientes com diabete tipo 1 submetidos a hemodi&#225;lise. Esses achados est&#227;o de acordo com outros estudos de aut&#243;psia, angiografia e USIV. Al&#233;m disso, eles indicam a necessidade de estudos adicionais epidemiol&#243;gicos e de imagem, para um melhor entendimento e tratamento de uma condi&#231;&#227;o cl&#237;nica complexa e grave que afeta jovens indiv&#237;duos.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Doen&#231;a coronariana</kwd>
        <kwd>diabetes mellitus tipo 1</kwd>
        <kwd>insufici&#234;ncia renal cr&#244;nica</kwd>
        <kwd>ultra-sonografia de interven&#231;&#227;o</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>13</day>
        <month>10</month>
        <year>2009</year>
      </pub-date>
    </article-meta>
  </front>
  <body><p>ARTIGO ORIGINAL </p><p> CORONARIOPATIA CR&#212;NICA</p><p><bold>Doen&#231;a arterial coronariana subcl&#237;nica em pacientes com <italic>Diabetes Mellitus</italic> tipo 1 em hemodi&#225;lise</bold></p><p><bold>Dinaldo Cavalcanti de Oliveira<sup>I,II</sup>; Fabio Sandoli de Brito Junior<sup>I,II</sup>; Rosley Weber Alvarenga Fernandes<sup>I,II</sup>; Jo&#227;o Roberto de Sa<sup>I,II</sup>; Valter Correia de Lima<sup>I,II</sup></bold></p><sup>I</sup>Hospital do Rim e Hipertens&#227;o - Funda&#231;&#227;o Oswaldo Ramos <p content-type="break"><sup>II</sup>Hospital S&#227;o Paulo - Universidade Federal de S&#227;o Paulo, S&#227;o Paulo, SP - Brasil </p><p><xref ref-type="corresp" rid="back">Correspond&#234;ncia</xref></p>     <p><bold>RESUMO</bold></p> <bold>FUNDAMENTO:</bold> A aterosclerose ocorre mais cedo em pacientes com diabetes mellitus tipo 1 (DM-1) e a doen&#231;a arterial coronariana (DAC) constitui a mais importante causa de morte. <p content-type="break"><bold>OBJETIVO:</bold> Avaliar a preval&#234;ncia e as caracter&#237;sticas anat&#244;micas da DAC em pacientes com DM-1 e insufici&#234;ncia renal cr&#244;nica, submetidos &#224; di&#225;lise. </p><p content-type="break"><bold>M&#201;TODOS:</bold> Este &#233; um estudo descritivo de 20 pacientes com DM-1 submetidos &#224; di&#225;lise sem DAC conhecida. A DAC foi avaliada atrav&#233;s de angiografia coronariana quantitativa (ACQ) e ultra-som intravascular (USIV). A ACQ foi realizada em todas as les&#245;es <underline>&gt;</underline>30%, visualmente Todos os segmentos proximais de 18 mm das art&#233;rias coron&#225;rias foram analisados por USIV. Todos os outros segmentos coronarianos com estenose <underline>&gt;</underline>30% tamb&#233;m foram analisados. </p><p content-type="break"><bold>RESULTADOS:</bold> A angiografia detectou 29 les&#245;es <underline>&gt;</underline>30% em 15 pacientes (75%). Onze (55%) das les&#245;es eram <underline>&gt;</underline>50% e 10 (50%) <underline>&gt;</underline>70%. Treze pacientes tiveram as 3 principais art&#233;rias avaliadas pelo USIV. A aterosclerose estava presente em todos os pacientes e em todos os 51 segmentos proximais de 18 mm analisados. Esses segmentos significam que a medida do di&#226;metro dos vasos apresentava-se significantemente maior no USIV do que na ACQ, em todos os vasos. As imagens do ISIV de 25 (86,2%) das 29 les&#245;es <underline>&gt;</underline>30% foram obtidas. Placas fibr&#243;ticas eram comuns (48%) e 60% apresentavam remodelamento intermedi&#225;rio de vasos. </p><p content-type="break"><bold>CONCLUS&#195;O:</bold> A DAC estava presente em todos os vasos de todos os pacientes com diabete tipo 1 submetidos a hemodi&#225;lise. Esses achados est&#227;o de acordo com outros estudos de aut&#243;psia, angiografia e USIV. Al&#233;m disso, eles indicam a necessidade de estudos adicionais epidemiol&#243;gicos e de imagem, para um melhor entendimento e tratamento de uma condi&#231;&#227;o cl&#237;nica complexa e grave que afeta jovens indiv&#237;duos.  </p><p><bold>Palavras-chave:</bold> Doen&#231;a coronariana, <italic>diabetes mellitus</italic> tipo 1, insufici&#234;ncia renal cr&#244;nica, ultra-sonografia de interven&#231;&#227;o.</p>     <p><bold>Introdu&#231;&#227;o</bold></p> <p>Em pacientes com <italic>diabetes mellitus</italic> tipo 1 (DM1), a aterosclerose ocorre mais cedo e a doen&#231;a arterial coronariana (DAC) &#233; a maior causa de morte<sup>1</sup>. Por volta dos 55 anos de idade, a taxa de mortalidade cumulativa devido a DAC tem sido relatada como sendo 30 a 40%<sup>2</sup>, que &#233; muito mais alta do que a taxa de mortalidade geral de 4% em indiv&#237;duos n&#227;o-diab&#233;ticos. De fato, em pacientes com DM1, o risco de mortalidade por DAC aumenta de 4 a 9 vezes em homens e 4 a 29 vezes em mulheres<sup>3</sup>. Esse risco &#233; ainda maior quando a protein&#250;ria ou insufici&#234;ncia renal est&#225; presente<sup>4,5</sup>. De fato, Tuomilehto e cols.<sup>6</sup> acompanharam 5.148 pacientes com DM1 por mais de dez anos e descobriram que quando a insufici&#234;ncia renal cr&#244;nica ocorre, a DAC se desenvolve mais cedo e muito mais frequentemente<sup>6</sup>.</p> <p>A despeito do crescente interesse epidemiol&#243;gico e cl&#237;nico, poucos estudos contempor&#226;neos t&#234;m sido realizados para caracterizar a DAC nesses individuos<sup>7-11</sup>, em oposi&#231;&#227;o aos pacientes com <italic>diabetes mellitus</italic> tipo 2.</p> <p>O objetivo do presente estudo foi avaliar a preval&#234;ncia e as caracter&#237;sticas qualitativas e quantitativas da DAC em pacientes com DM1 com insufici&#234;ncia renal cr&#244;nica, submetidos &#224; hemodi&#225;lise.</p>   <p><bold>M&#233;todos</bold></p> <p>Pacientes com DM1 submetidos &#224; hemodi&#225;lise sem DAC conhecida foram prospectivamente inclu&#237;dos nesse estudo observacional e descritivo. Todos os pacientes foram submetidos &#224; exames bioqu&#237;micos e hematol&#243;gicos padr&#227;o. A avalia&#231;&#227;o cardiol&#243;gica incluiu eletrocardiograma, ecocardiograma com Doppler e teste isqu&#234;mico.</p> <p>O protocolo do estudo foi aprovado pelo Comit&#234; de &#201;tica da Universidade Federal de S&#227;o Paulo e o consentimento livre e informado foi obtido por escrito de todos os participantes.</p> <p><bold>Angiografia coronariana quantitativa e an&#225;lise de ultra-som intravascular</bold></p> <p>Nitroglicerina (300 &#181;g) foi administrada imediatamente antes dos angiogramas e avalia&#231;&#245;es por ultra-som intravascular (USIV). A an&#225;lise visual dos angiogramas coronarianos foi realizada por dois angiografistas experientes. A porcentagem do di&#226;metro da estenose das les&#245;es foi estimada e os pacientes foram classificados como tendo art&#233;rias normais, les&#245;es &lt; 30% ou les&#245;es <underline>&gt;</underline> 30%. A Angiografia Coronariana Quantitativa (ACQ) foi realizada em todas as les&#245;es <underline>&gt;</underline> 30%, usando um algoritmo de detec&#231;&#227;o de borda automatizado (<italic>QCA CMS System, MEDIS Medical Imaging Systems, Leiden</italic>, Pa&#237;ses Baixos). O comprimento da les&#227;o, di&#226;metro m&#237;nimo do <italic>l&#250;men</italic>, di&#226;metro de referencia e porcentagem do di&#226;metro da estenose foram medidos nesses locais.</p> <p>O estudo de imagem por USIV foi realizado atrav&#233;s de sistemas mec&#226;nicos (Clear View ou Galaxy, Boston Scientific, Sunnyvale, CA, EUA) com cateter de ultra-som de 30 MHz com um sistema de retirada (<italic>pullback)</italic> motorizado de 0,5 mm/s. O registro do USIV foi iniciado no segmento mais distal de cada vaso com di&#226;metro maior que 2 mm. De maneira adequada, pelo menos metade do comprimento total dos vasos foi estudada. A grava&#231;&#227;o da fita de S-VHS foi usada para mensura&#231;&#245;es <italic>off-line</italic> usando um <italic>software</italic> de an&#225;lise dedicado para USIV (QIVA, Pie Medical, Pa&#237;ses Baixos). Para essa an&#225;lise, o segmento de 18 mm mais proximal das principais art&#233;rias coronarianas foi arbitrariamente selecionado. Al&#233;m disso, todos os outros segmentos na &#225;rvore coronariana que apresentavam estenose <underline>&gt;</underline> 30% na angiografia foram analisados.</p> <p>As seguintes medidas foram realizadas nos segmentos coronarianos de 18 mm proximais: &#225;reas transversais (AT) do vaso, <italic>l&#250;men</italic> e placa e m&#225;xima espessura da placa, a cada mil&#237;metro<sup>12</sup>. Baseado nessas medidas, os volumes do vaso, <italic>l&#250;men</italic> e placa foram calculados. A AT m&#237;nima do <italic>l&#250;men</italic> tamb&#233;m foi obtida. Placas ateroscler&#243;ticas foram consideradas presentes quando a espessura da &#237;ntima excedia 0,3 mm<sup>13</sup>. A distribui&#231;&#227;o axial da placa ao longo de cada um desses segmentos coronarianos foi avaliada atrav&#233;s do c&#225;lculo de seu coeficiente de varia&#231;&#227;o, dividindo a AT m&#233;dia da placa pelo desvio-padr&#227;o da AT da placa.</p> <p>Nos segmentos selecionados para an&#225;lise da presen&#231;a de estenose <underline>&gt;</underline> 30%, a AT do <italic>l&#250;men</italic>, vaso e placa foi medida no local com a AT m&#237;nima do <italic>l&#250;men</italic>. O grau de comprometimento foi calculado como: (AT placa/AT vaso no local da les&#227;o) x 100. Os s&#237;tios de refer&#234;ncia distal e proximal foram definidos como as &#225;reas transversais com a menor quantidade da doen&#231;a e o maior <italic>l&#250;men</italic> dentro de um limite de 10 mm da les&#227;o. Nesses s&#237;tios, a AT do vaso e do <italic>l&#250;men</italic> foi medida. A m&#233;dia da AT do <italic>l&#250;men</italic> das referencias distal e proximal foi considerada como a AT de refer&#234;ncia do <italic>l&#250;men</italic>. A estenose da &#225;rea do <italic>l&#250;men</italic> foi calculada como: [(AT de refer&#234;ncia do <italic>l&#250;men</italic> menos AT do <italic>l&#250;men</italic> no sitio da les&#227;o / AT de refer&#234;ncia do <italic>l&#250;men</italic>) x 100]. O remodelamento do vaso foi determinado baseado na seguinte defini&#231;&#227;o: o remodelamento adaptativo foi considerada presente quando a AT do vaso no local da les&#227;o era maior do que a AT do vaso na refer&#234;ncia proximal; remodelamento constritivo foi considerado presente quando a AT do vaso no s&#237;tio da les&#227;o era menor que a AT do vaso na refer&#234;ncia distal e remodelamento intermedi&#225;rio estava presente quando a AT do vaso no s&#237;tio da les&#227;o era intermedi&#225;rio entre a AT do vaso nas refer&#234;ncias distal e proximal<sup>14</sup>. Um &#237;ndice de remodelamento foi calculado como AT do vaso no s&#237;tio da les&#227;o dividido pela AT do vaso na refer&#234;ncia proximal<sup>15</sup>. No s&#237;tio da les&#227;o, a composi&#231;&#227;o da placa foi classificada como mole, fibr&#243;tica ou fibrocalcificada, de acordo com suas caracter&#237;sticas<sup>12</sup>. As mensura&#231;&#245;es por ACQ e USIV foram realizadas no laborat&#243;rio central do Hospital Israelita Albert Einstein (S&#227;o Paulo, Brasil).</p> <p><bold>An&#225;lise estat&#237;stica</bold></p> <p>Dados quantitativos foram apresentados como o valor m&#233;dio &#177; DP e os dados qualitativos foram apresentados como frequ&#234;ncias.</p> <p>Para estudar a associa&#231;&#227;o entre a presen&#231;a de estenose <underline>&gt;</underline> 30%, idade e DM1, o teste <italic>t</italic> de Student foi aplicado. O mesmo teste foi utilizado para comparar o di&#226;metro m&#233;dio do vaso dos 18 mm proximais pelo USIV e angiografia.</p> <p>A busca por uma associa&#231;&#227;o entre a espessura m&#225;xima da placa e o volume da placa nos 18 mm mais proximais das art&#233;rias coron&#225;rias e idade, colesterol s&#233;rico, &#237;ndice de massa corporal, dura&#231;&#227;o da hemodi&#225;lise e dura&#231;&#227;o do diabetes foi realizada atrav&#233;s do c&#225;lculo do coeficiente de correla&#231;&#227;o linear de Pearson. Todos os testes de signific&#226;ncia foram bi-caudais e os valores de p&lt; 0,05 foram considerados significantes.</p>   <p><bold>Resultados</bold></p> <p><bold>Popula&#231;&#227;o do estudo</bold></p> <p>De fevereiro a novembro de 2003, 20 pacientes foram recrutados. As caracter&#237;sticas demogr&#225;ficas e cl&#237;nicas s&#227;o mostradas na <xref ref-type="table" rid="t1">Tabela 1</xref>. Apenas dois pacientes (10%) apresentaram isquemia mioc&#225;rdica nos testes funcionais.</p> <table-wrap id="t1"><graphic xlink:href="1678-4170-abc-93-01-0015-00004-gt01.jpg"/></table-wrap>   <p><bold>An&#225;lise angiogr&#225;fica</bold></p> <p>A avalia&#231;&#227;o visual dos angiogramas coronarianos detectou 29 les&#245;es <underline>&gt;</underline> 30% em 15 (75%) pacientes [1,93 &#177; 1,03 les&#245;es por paciente (<xref ref-type="table" rid="t2">Tabela 2</xref>)]. Onze (55%) deles apresentavam les&#245;es <underline>&gt;</underline> 50% e 10 (50%) les&#245;es <underline>&gt;</underline> 70%. Um paciente apresentava oclus&#227;o proximal da art&#233;ria descendente anterior esquerda (ADE). Um dos pacientes com teste isqu&#234;mico positivo apresentava estenose em todos os tr&#234;s vasos [ADE: 50%, circunflexa esquerda (CXE): 80% e art&#233;ria coron&#225;ria direita (ACD): 40%]. O outro apresentava estenose em dois vasos (ADE: 70% e ACD: 50%).</p> <table-wrap id="t2"><graphic xlink:href="1678-4170-abc-93-01-0015-00004-gt02.jpg"/></table-wrap>   <p><bold>An&#225;lise por ultra-som intravascular</bold></p> <p>Imagens por USIV do segmento de 18 mm mais proximal de pelo menos uma das grandes art&#233;rias coron&#225;rias foram obtidas de todos os pacientes. Treze pacientes tiveram as tr&#234;s principais art&#233;rias avaliadas; 5 pacientes tiveram 2 e 2 pacientes tiveram apenas uma art&#233;ria principal avaliada. Aterosclerose estava presente em todos os pacientes e em todos os 51 segmentos de 18 mm mais proximais analisados (18 ADE, 18 CXE e 15 ACD). Nesses segmentos, havia grande quantidade de aterosclerose, com distribui&#231;&#227;o difusa (<xref ref-type="fig" rid="f1">Fig. 1</xref>). Em 9 (17,6%) segmentos, a AT m&#237;nima do <italic>l&#250;men</italic> foi <underline>&lt;</underline> 4 mm<sup>2</sup>. O volume da placa, m&#225;xima espessura da placa, AT m&#237;nima do <italic>l&#250;men</italic> e coeficiente de varia&#231;&#227;o axial da &#225;rea da placa para esses segmentos s&#227;o mostrados na <xref ref-type="table" rid="t3">Tabela 3</xref>. A medida m&#233;dia do di&#226;metro do vaso dos segmentos proximais era significantemente maior no USIV do que na ACQ, em todos os vasos: [18 segmentos ADE: 4,24 &#177; 0,45 vs. 3,30 &#177; 0,59 (p&lt;0,001)]; [18 segmentos CXE: 3,64 &#177; 0,60 vs. 3.20 &#177; 0.56 (p=0.02)]; [15 segmentos ACD: 4,35 &#177; 0,56 vs. 3,82 &#177; 0,56 (p=0,01)]. As imagens por USIV de 25 (86,2%) das 29 les&#245;es <underline>&gt;</underline> 30% foram obtidas. Placas fibr&#243;ticas eram mais comuns (48%) e a maioria apresentava remodelamento intermedi&#225;rio de vasos (60%). As caracter&#237;sticas da placa, grau de comprometimento, estenose da &#225;rea do <italic>l&#250;men</italic> e AT m&#237;nima do <italic>l&#250;men</italic> dessas les&#245;es s&#227;o mostradas na <xref ref-type="table" rid="t3">Tabela 3</xref>.</p> <fig id="f1"><graphic xlink:href="1678-4170-abc-93-01-0015-00004-gf01.jpg"/></fig>   <table-wrap id="t3"><graphic xlink:href="1678-4170-abc-93-01-0015-00004-gt03.jpg"/></table-wrap>   <p>A idade e a dura&#231;&#227;o da <italic>diabetes mellitus</italic> estavam relacionadas com maior espessura de placa, volume de placa e a presen&#231;a de les&#245;es <underline>&gt;</underline> 30% (<xref ref-type="fig" rid="f02">Fig. 2</xref>).</p><p content-type="asset"><fig id="f02"><graphic xlink:href="1678-4170-abc-93-01-0015-00004-gf02.jpg"/></fig></p>   <p><bold>Discuss&#227;o</bold></p> <p>O achado mais importante desse estudo foi o envolvimento difuso do vaso e a grande quantidade de aterosclerose vista atrav&#233;s das imagens do USIV nessa popula&#231;&#227;o selecionada com <italic>diabetes mellitus</italic> tipo 1 e doen&#231;a renal terminal (DRT). Verificamos uma distribui&#231;&#227;o relativamente uniforme de placa ao longo dos segmentos de 18 mm mais proximais, como demonstrado pelo baixo coeficiente de varia&#231;&#227;o axial da &#225;rea de placa (33,6 &#177; 10%). Adicionalmente, a quantifica&#231;&#227;o da placa nesses segmentos demonstrou a exist&#234;ncia de uma grande massa de placa, atrav&#233;s do volume de placa corrigido axialmente (4,6 &#177; 2,4 mm<sup>3</sup>/mm) e pela m&#225;xima espessura da &#237;ntima (1,49 &#177; 0,71 mm).</p> <p>O desenvolvimento de aterotrombose na presen&#231;a de nefropatia tem sido atribu&#237;do a v&#225;rios mecanismos, incluindo hipertens&#227;o, dislipidemia e anormalidades de fibrin&#243;lise e coagula&#231;&#227;o. A nefropatia diab&#233;tica est&#225; associada com um perfil aterog&#234;nico de lipoprote&#237;nas, incluindo eleva&#231;&#227;o dos n&#237;veis de lipoprote&#237;na de baixa densidade, lipoprote&#237;na de muito baixa densidade e lipoprote&#237;na e diminui&#231;&#227;o dos n&#237;veis de lipoprote&#237;na de alta densidade. Al&#233;m disso, um estado hipercoagul&#225;vel, caracterizado pelo aumento do inibidor do ativador do plasminog&#234;nio-1, fator VIII e n&#237;veis de fibrinog&#234;nio plasm&#225;tico tem sido descrito. Fun&#231;&#227;o renal reduzida pode levar ao ac&#250;mulo de produtos avan&#231;ados de glicosila&#231;&#227;o na circula&#231;&#227;o e em tecidos, o que pode acelerar a aterosclerose<sup>16</sup>.</p> <p>Considerando os par&#226;metros angiogr&#225;ficos, a alta preval&#234;ncia de les&#245;es significantes replicou os achados previamente relatados por n&#243;s em pacientes com diabete tipo 1 submetidos &#224; angiografia para avalia&#231;&#227;o de DAC antes de transplante duplo de p&#226;ncreas e rim<sup>8</sup>.</p> <p>A quantidade e a extens&#227;o da aterosclerose encontrada pelo USIV em nossa investiga&#231;&#227;o est&#227;o de acordo com os resultados relatados em um estudo de necropsia de nove indiv&#237;duos com idade m&#233;dia de 29 anos na &#233;poca da morte<sup>17</sup>.</p> <p>Neste estudo, 90,5 cm (47%) do total de 191 cm de segmento de art&#233;rias coron&#225;rias avaliadas apresentavam mais de 50% de estenose da &#225;rea transversal, comparados com apenas 2 cm do total de 155 cm do grupo controle de mesmo sexo e idade similar. Outro estudo coron&#225;rio com USIV em diabete tipo 1 tamb&#233;m relatou que todos os pacientes tinham DAC<sup>11</sup>. &#201; interessante notar que esses resultados foram obtidos em uma popula&#231;&#227;o menos doente, quando comparada com a nossa, porque os indiv&#237;duos com creatinina &gt; 150 &#181;mol/l e nefropatia manifesta (excre&#231;&#227;o de albumina urin&#225;ria &gt; 300 mg/24 h) foram exclu&#237;dos.</p> <p>Larsen e cols.<sup>18</sup> mostraram que o grau de aterosclerose coron&#225;ria subcl&#237;nica era significantemente mais grave em pacientes com diabetes tipo 1 do que nos controles.A &#225;rea m&#233;dia da placa (pelo USIV) era <underline>&gt;</underline> 40% em 71% das art&#233;rias dos pacientes diab&#233;ticos quando comparada com 33% das art&#233;rias dos controles (p &lt; 0,001).</p> <p>&#201; interessante notar que nosso estudo mostrou a predomin&#226;ncia das les&#245;es ateroscler&#243;ticas com caracter&#237;sticas de estabilidade, representadas por sua composi&#231;&#227;o fibr&#243;tica com remodelamento negativo ou intermedi&#225;rio. Entretanto, mesmo considerando a porcentagem mais baixa de placas potencialmente vulner&#225;veis (composi&#231;&#227;o lip&#237;dica com remodelagem positiva), o enorme volume da doen&#231;a faz com que sejam um achado frequente na &#225;rvore coron&#225;ria de pacientes com <italic>diabetes mellitus</italic> tipo 1 e DRT, o que poderia explicar as altas taxas de eventos adversos nessa popula&#231;&#227;o.</p> <p>Ao relacionarmos as vari&#225;veis cl&#237;nicas com a aterosclerose coronariana, descobrimos que idade e a dura&#231;&#227;o da diabete estavam relacionadas com maior espessura da placa, volume de placa e a presen&#231;a de les&#245;es <underline>&gt;</underline> 30%. N&#227;o encontramos nenhuma correla&#231;&#227;o entre aterosclerose coronariana e n&#237;veis s&#233;ricos de colesterol, fumo, &#237;ndice de massa corporal e o procedimento de hemodi&#225;lise. Para poucas dessas vari&#225;veis, a falta de correla&#231;&#227;o pode ser devida a erro beta. Em outro estudo<sup>19</sup>, um aumento de 1% na HbA<sub>1c</sub> m&#233;dia durante 18 anos implicou em um aumento de 6.4% no grau de comprometimento das coron&#225;rias, 15 mg de aumento no colesterol total implicou em 10% aumento no grau de comprometimento e um aumento de 10 anos na idade implicou em um aumento de 16,2% no grau de comprometimento.</p> <p>&#201; sabido que a angiografia subestima o di&#226;metro do vaso e a extens&#227;o da aterosclerose, quando comparada ao USIV e h&#225; tr&#234;s preditores para essa discrep&#226;ncia: di&#226;metro do vaso pela angiografia &lt; 3 mm, segmentos proximais e diabete, presumidamente tipo 2. Nosso estudo &#233; o primeiro a abordar esse assunto em pacientes com diabete tipo 1<sup>20</sup>.</p> <p>O estudo de imagem por resson&#226;ncia magn&#233;tica e tomografia computadorizada (atrav&#233;s da avalia&#231;&#227;o do conte&#250;do de c&#225;lcio na art&#233;ria coron&#225;ria) pode identificar DAC subcl&#237;nica<sup>16,21</sup>. O escore de c&#225;lcio tem sido utilizado para avaliar a preval&#234;ncia e o progn&#243;stico da DAC em pacientes com diabete tipo 1<sup>22,23</sup>. Entretanto, em pacientes com DRT, a rela&#231;&#227;o do c&#225;lcio coronariano com a aterosclerose coronariana ainda n&#227;o foi t&#227;o bem estabelecida<sup>24</sup>.</p> <p>Atualmente, uma melhor caracteriza&#231;&#227;o da DAC em pacientes com diabete tipo 1 com DRT submetidos &#224; di&#225;lise tem se tornado mais importante, considerando a crescente disponibilidade de transplantes duplos de p&#226;ncreas e rim. Esse moderno tratamento pode melhorar o resultado cardiovascular nesses pacientes. De fato, tem sido relatado que a progress&#227;o da DAC &#233; reduzida, com base nos resultados da angiografia realizada antes do transplante e quatro anos depois<sup>25</sup>.</p> <p>O presente estudo tem duas principais limita&#231;&#245;es: o n&#250;mero limitado de pacientes e a falta de informa&#231;&#245;es sobre o controle glic&#234;mico de longo prazo.</p>   <p><bold>Conclus&#227;o</bold></p> <p>Em resumo, a DAC subcl&#237;nica est&#225; presente em todos os vasos de todos os pacientes com <italic>diabetes mellitus</italic> tipo 1 submetidos &#224; di&#225;lise. Isso indica a necessidade de estudos adicionais epidemiol&#243;gicos e de imagem, para um melhor entendimento e tratamento de uma condi&#231;&#227;o clinica complexa e grave que afeta jovens indiv&#237;duos.</p> <p><bold>Potencial Conflito de Interesses</bold></p> <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p> <p><bold>Fontes de Financiamento</bold></p> <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p> <p><bold>Vincula&#231;&#227;o Acad&#234;mica</bold></p> <p>Este artigo &#233; parte de tese de doutorado de Dinaldo Cavalcanti de Oliveira pela Universidade Federal de S&#227;o Paulo.</p>                                 <p><fn id="back" fn-type="corresp"><label><bold> Correspond&#234;ncia:</bold></label><p>Dinaldo Cavalcanti de Oliveira  </p><p>Rua Ab&#237;lio Soares, 625 / 64 A, Para&#237;so </p><p> 04005-002, S&#227;o Paulo, SP - Brasil </p><p>E-mail: </p><p><email xlink:href="dinaldo@cardiol.br">dinaldo@cardiol.br</email>, </p><p><email xlink:href="doliveira@hcor.com.br">doliveira@hcor.com.br</email></p></fn></p> <p>Artigo recebido em 26/01/2008; artigo revisado recebido em 19/06/2008; aceito em 19/06/2008.</p></body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Libby P, Nathan    D, Abraham K, Brunzell JD, Fradkin JE, Haffner SM, et al. Report of the National    Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive    and Kidney Diseases Working Group on Cardiovascular Complications of Type 1    <italic>Diabetes Mellitus</italic>. Circulation. 2005; 111: 3489-93.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus</article-title>
          <source>Circulation</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>3489</fpage>
          <lpage>93</lpage>
          <volume>111</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Libby</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Nathan</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Abraham</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Brunzell</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Fradkin</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Haffner</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Krolewski AS,    Warram JH, Rand LI, Kahn RC. Epidemiologic approach to the etiology of type    1 <italic>diabetes mellitus</italic> and its complications. N Engl J Med. 1987; 317: 1390-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Epidemiologic approach to the etiology of type 1 diabetes mellitus and its complications</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>1987</year>
          </date>
          <fpage>1390</fpage>
          <lpage>8</lpage>
          <volume>317</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Krolewski</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Warram</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Rand</surname>
              <given-names>LI</given-names>
            </name>
            <name>
              <surname>Kahn</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Laing SP, Swerlow    AJ, Slater SD, Burden AC, Morris A, Waugh NR, et al. Mortality from heart disease    in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia.    2003; 46: 760-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes</article-title>
          <source>Diabetologia</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>760</fpage>
          <lpage>5</lpage>
          <volume>46</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Laing</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Swerlow</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Slater</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Burden</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Morris</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Waugh</surname>
              <given-names>NR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Jensen T, Borch-Johnsen    K, Kofoed-Enevoldsen A, Deckert T. Coronary heart disease in young type 1 (insulin-dependent)    diabetic patients with and without diabetic nephropathy: incidence and risk    factors. Diabetologia. 1987; 30: 144-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors</article-title>
          <source>Diabetologia</source>
          <date>
            <year>1987</year>
          </date>
          <fpage>144</fpage>
          <lpage>8</lpage>
          <volume>30</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Jensen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Borch-Johnsen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kofoed-Enevoldsen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Deckert</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Foley RN, Culleton    BF, Parfrey PS, Harnett JD, Kent GM, Barre PE. Cardiac disease in diabetic end-stage    renal disease. Diabetologia. 1997; 40: 1307-12.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac disease in diabetic end-stage renal disease</article-title>
          <source>Diabetologia</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>1307</fpage>
          <lpage>12</lpage>
          <volume>40</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Foley</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Culleton</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>Parfrey</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Harnett</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Kent</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Barre</surname>
              <given-names>PE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Tuomilehto J,    Borch-Johnsen K, Molatirus A, Molarius A, Forsen T, Rastenyte D, et al. Incidence    of cardiovascular disease in type 1 (insulin dependent) diabetic subjects with    and without diabetic nephropathy in Finland. Diabetologia. 1998; 41: 784-90.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Incidence of cardiovascular disease in type 1 (insulin dependent) diabetic subjects with and without diabetic nephropathy in Finland</article-title>
          <source>Diabetologia</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>784</fpage>
          <lpage>90</lpage>
          <volume>41</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Tuomilehto</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Borch-Johnsen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Molatirus</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Molarius</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Forsen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Rastenyte</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Manske CL, Wilson    RF, Wang Y, Thomas W. Prevalence of, and risk factors for, angiographic determined    coronary artery disease in type I diabetic patients with nephropathy. Arch Intern    Med. 1992; 152: 2450-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevalence of, and risk factors for, angiographic determined coronary artery disease in type I diabetic patients with nephropathy</article-title>
          <source>Arch Intern Med</source>
          <date>
            <year>1992</year>
          </date>
          <fpage>2450</fpage>
          <lpage>5</lpage>
          <volume>152</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Manske</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Oliveira DC,    Gusm&#227;o G, Nakamoto A, Souza FL, S&#225; JR, Pestana JO, et al. Prevalence    of coronary artery disease in type 1 diabetic patients candidates for double    transplantation (kidney and pancreas). Arq Bras Cardiol. 2005; 84: 108-10.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prevalence of coronary artery disease in type 1 diabetic patients candidates for double transplantation (kidney and pancreas)</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>108</fpage>
          <lpage>10</lpage>
          <volume>84</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Oliveira</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Gusm&#227;o</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Nakamoto</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>S&#225;</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Pestana</surname>
              <given-names>JO</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Ramanathan V,    Goral S, Tanriover B, Feurer JD, Kazancioglu R, Shaffer D, et al. Screening    asymptomatic diabetic patients for coronary artery disease prior to renal transplantation.    Transplantation. 2005; 79: 1453-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Screening asymptomatic diabetic patients for coronary artery disease prior to renal transplantation</article-title>
          <source>Transplantation</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>1453</fpage>
          <lpage>8</lpage>
          <volume>79</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ramanathan</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Goral</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tanriover</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Feurer</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Kazancioglu</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Shaffer</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Senior PA,    Welsh RC, McDonald CG, Paty BW, Shapiro AMJ, Ryan EA. Coronary artery disease    is common in non uremic, asymptomatic type 1 diabetic islet transplantation    candidates. Diabetes Care. 2005; 28: 866-72.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Coronary artery disease is common in non uremic, asymptomatic type 1 diabetic islet transplantation candidates</article-title>
          <source>Diabetes Care</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>866</fpage>
          <lpage>72</lpage>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Senior</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Welsh</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>McDonald</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Paty</surname>
              <given-names>BW</given-names>
            </name>
            <name>
              <surname>Shapiro</surname>
              <given-names>AMJ</given-names>
            </name>
            <name>
              <surname>Ryan</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Larsen JR,    Brekke M, Sandvik L, Arnesen H, Hanssen KF, Jorgensen KD. Silent coronary atheromatosis    in type 1 diabetic patients and its relation to long term glycemic control.    Diabetes. 2002; 51: 2637-41.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Silent coronary atheromatosis in type 1 diabetic patients and its relation to long term glycemic control</article-title>
          <source>Diabetes</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>2637</fpage>
          <lpage>41</lpage>
          <volume>51</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Larsen</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Brekke</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sandvik</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Arnesen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hanssen</surname>
              <given-names>KF</given-names>
            </name>
            <name>
              <surname>Jorgensen</surname>
              <given-names>KD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Mintz GS, Nissen    SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, et al. American College    of Cardiology Clinical Expert Consensus Document on Standards for Acquisition,    Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report    of the American College of Cardiology Task Force on Clinical Expert Consensus    Documents. J Am Coll Cardiol. 2001; 37: 1478-92.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS): A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>1478</fpage>
          <lpage>92</lpage>
          <volume>37</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Mintz</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Nissen</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Bailey</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Erbel</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Fitzgerald</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Nissen SE,    Gurley JC, Erines CL, Grines CL, Booth DC, McClure R, Berk M, et al. Intravascular    ultrasound assessment of lumen size and wall morphology in normal subjects and    patients with coronary artery disease. Circulation. 1991; 84: 1087-99.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease</article-title>
          <source>Circulation</source>
          <date>
            <year>1991</year>
          </date>
          <fpage>1087</fpage>
          <lpage>99</lpage>
          <volume>84</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Nissen</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Gurley</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Erines</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Grines</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Booth</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>McClure</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Berk</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Tauth J, Pinnow    E, Sellebarger T, Sullebarger JT, Basta L, Gursoy S, et al. Predictors of coronary    arterial remodeling patterns in patients with myocardial ischemic. Am J Cardiol.    1997; 80: 1352-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Predictors of coronary arterial remodeling patterns in patients with myocardial ischemic</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>1352</fpage>
          <lpage>5</lpage>
          <volume>80</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Tauth</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pinnow</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Sellebarger</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sullebarger</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Basta</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Gursoy</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Sabat&#233;    M, Kay P, Feyter PJ, van Domburg RT, Deshpande NV, Ligthart JM, et al. Remodeling    of atherosclerotic coronary arteries varies in relation to location and composition    of plaque. Am J Cardiol. 1999; 84: 135-40.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Remodeling of atherosclerotic coronary arteries varies in relation to location and composition of plaque</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>135</fpage>
          <lpage>40</lpage>
          <volume>84</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sabat&#233;</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kay</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Feyter</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>van Domburg</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Deshpande</surname>
              <given-names>NV</given-names>
            </name>
            <name>
              <surname>Ligthart</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Kim WY, Astrup    AS, Stuber M, Tarnow L, Falk E, Botnar RM, et al. Subclinical coronary and atherosclerosis    detected by magnetic resonance imaging in type 1 diabetes with and without diabetic    nephropathy. Circulation. 2007; 115: 228-35.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Subclinical coronary and atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy</article-title>
          <source>Circulation</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>228</fpage>
          <lpage>35</lpage>
          <volume>115</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>WY</given-names>
            </name>
            <name>
              <surname>Astrup</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Stuber</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tarnow</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Falk</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Botnar</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Crall FV, Roberts    WC. The extramural and intramural coronary arteries in juvenile <italic>diabetes    mellitus</italic>: analysis of nine necropsy patients aged 19 to 38 years with onset    of diabetes before age 15 years. Am J Med. 1978; 64: 221-30.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The extramural and intramural coronary arteries in juvenile diabetes mellitus: analysis of nine necropsy patients aged 19 to 38 years with onset of diabetes before age 15 years</article-title>
          <source>Am J Med</source>
          <date>
            <year>1978</year>
          </date>
          <fpage>221</fpage>
          <lpage>30</lpage>
          <volume>64</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Crall</surname>
              <given-names>FV</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>WC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Larsen JR,    Tsunoda T, Tuzcu EM, Schoenhagen P, Brekke M, Arnesen H, et al. Intracoronary    ultrasound examinations reveal significantly more advanced coronary atherosclerosis    in people with type 1 diabetes than in age- and sex-matched non-diabetic controls.    Diab Vasc Dis Res. 2007; 4: 62-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Intracoronary ultrasound examinations reveal significantly more advanced coronary atherosclerosis in people with type 1 diabetes than in age- and sex-matched non-diabetic controls</article-title>
          <source>Diab Vasc Dis Res</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>62</fpage>
          <lpage>5</lpage>
          <volume>4</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Larsen</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Tsunoda</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tuzcu</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Schoenhagen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Brekke</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Arnesen</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Tuzcu EM, Kapadia    SR, Tutar E, Ziada KM, Hobbs RE, McCarthy PM, et al. High prevalence of coronary    atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular    ultrasound. Circulation. 2001; 103: 2705-10.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound</article-title>
          <source>Circulation</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>2705</fpage>
          <lpage>10</lpage>
          <volume>103</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Tuzcu</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Kapadia</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Tutar</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ziada</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Hobbs</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>McCarthy</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Moussa I, Kobayashi    Y, Adamian M, Hirose M, Di Mario C, Moses J, et al. Characteristics of patients    with a large discrepancy in coronary artery diameter between quantitative angiography    and intravascular ultrasound. Am J Cardiol. 2001; 88: 294-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Characteristics of patients with a large discrepancy in coronary artery diameter between quantitative angiography and intravascular ultrasound</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>294</fpage>
          <lpage>6</lpage>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Moussa</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Adamian</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hirose</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Di Mario</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Moses</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Gottlieb I,    Lima JAC. Should all high-risk patients be screened with computed tomography    angiography ? Circulation. 2008; 117: 1318-32.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Should all high-risk patients be screened with computed tomography angiography ?</article-title>
          <source>Circulation</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>1318</fpage>
          <lpage>32</lpage>
          <volume>117</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Gottlieb</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>JAC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Costacou T,    Edmundowicz D, Prince C, Conway B, Orchard TJ. Progression of coronary artery    calcium in type 1 <italic>diabetes mellitus</italic>. Am J Cardiol. 2007; 100: 1543-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Progression of coronary artery calcium in type 1 diabetes mellitus</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>1543</fpage>
          <lpage>7</lpage>
          <volume>100</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Costacou</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Edmundowicz</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Prince</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Conway</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Orchard</surname>
              <given-names>TJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Thilo C, Standal    E, Knez A, Reiser M, Steinbeck G, Haberl R, et al. Coronary calcification in    long-term type 1 diabetic patients: a study with multi slice spiral computed    tomography. Exp Clin Endocrinol Diabetes. 2004; 112: 561-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Coronary calcification in long-term type 1 diabetic patients: a study with multi slice spiral computed tomography</article-title>
          <source>Exp Clin Endocrinol Diabetes</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>561</fpage>
          <lpage>5</lpage>
          <volume>112</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Thilo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Standal</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Knez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Reiser</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Steinbeck</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Haberl</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Achenbach S,    Daniel WG. Computed tomography of the heart. In: Libby P. Braunwald's heart    disease: a textbook of cardiovascular medicine. 8th ed. Philadelphia: Saunders    Elsevier Company; 2008. p. 415-35.</mixed-citation>
        <element-citation publication-type="book">
          <source>Braunwald's heart disease: a textbook of cardiovascular medicine</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>415</fpage>
          <lpage>35</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Achenbach</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Daniel</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Libby</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Jukema JW,    Smets YFC, van der Pijl JW, Zwiderman AH, Vliegen HW, Ringers J, et al. Impact    of simultaneous pancreas and kidney transplantation on progression of coronary    atherosclerosis in patients with end stage renal failure due to type 1 diabetes.    Diabetes Care. 2002; 25: 906-11.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Impact of simultaneous pancreas and kidney transplantation on progression of coronary atherosclerosis in patients with end stage renal failure due to type 1 diabetes</article-title>
          <source>Diabetes Care</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>906</fpage>
          <lpage>11</lpage>
          <volume>25</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Jukema</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Smets</surname>
              <given-names>YFC</given-names>
            </name>
            <name>
              <surname>van der Pijl</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Zwiderman</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Vliegen</surname>
              <given-names>HW</given-names>
            </name>
            <name>
              <surname>Ringers</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Subclinical coronary artery disease in patients with type 1 Diabetes Mellitus undergoing hemodialysis</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: In patients with type 1 diabetes mellitus, atherosclerosis occurs earlier in life and coronary artery disease (CAD) constitutes the major cause of death. OBJECTIVE: Evaluate the prevalence and anatomic characteristics of coronary artery disease (CAD) in type 1 diabetic patients with chronic renal failure undergoing hemodialysis. METHODS: This is a descriptive study of 20 patients with type 1 diabetes mellitus undergoing hemodialysis without known CAD. CAD was assessed by quantitative coronary angiography (QCA) and intravascular ultrasound (IVUS). QCA was performed in all lesions &gt;30%, visually. All proximal 18-mm segments of the coronary arteries were analyzed by IVUS. All other coronary segments with stenosis &gt;30% were also analyzed. RESULTS: Angiography detected 29 lesions &gt;30% in 15 patients (75%). Eleven (55%) of the lesions were &gt;50% and 10 (50%) &gt;70%. Thirteen patients had all 3 major arteries interrogated by IVUS. Atherosclerosis was present in all patients and in all 51 proximal 18-mm segments analyzed. The mean vessel diameter of these segments was significantly larger at the IVUS than at the QCA, for all vessels. IVUS images of 25 (86.2%) of the 29 lesions &gt;30% were obtained. Fibrotic plaques were common (48%) and 60% had intermediate vessel remodeling. CONCLUSION: CAD was present in all vessels of all type 1 diabetic patients undergoing hemodialysis. These findings are in agreement with other autopsy, angiography and IVUS studies. Additionally, they indicate the need for additional epidemiological and imaging studies to better understand and treat such a complex and serious clinical condition affecting young people.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Coronary artery disease</kwd>
        <kwd>diabetes mellitus type 1</kwd>
        <kwd>ultrasonography interventional</kwd>
        <kwd>renal insufficiency chronic</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ORIGINAL ARTICLE</bold>
      </p>
      <p>
        <fn id="top-body2">
          <label>
            <bold>Subclinical coronary artery disease in patients with type 1 <italic>diabetes mellitus</italic> undergoing hemodialysis</bold>
          </label>
          <p>
            <bold>Dinaldo Cavalcanti de Oliveira<sup>I, II</sup>; Fabio Sandoli de Brito Junior<sup>I, II</sup>; Rosley Weber Alvarenga Fernandes<sup>I, II</sup>; Jo&#227;o Roberto de Sa<sup>I, II</sup>; Valter Correia de Lima<sup>I, II</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Hospital do Rim e Hipertens&#227;o - Funda&#231;&#227;o Oswaldo Ramos, S&#227;o Paulo, SP - Brazil</p>
      <p><sup>II</sup>Hospital S&#227;o Paulo - Universidade Federal de S&#227;o Paulo, S&#227;o Paulo, SP - Brazil</p>
      <p>Mailing address</p>
      <p>
        <bold>SUMMARY</bold>
      </p>
      <p><bold>BACKGROUND: </bold> In patients with type 1 <italic>diabetes mellitus</italic>, atherosclerosis occurs earlier in life and coronary artery disease (CAD) constitutes the major cause of death.</p>
      <p><bold>OBJECTIVE:</bold> Evaluate the prevalence and anatomic characteristics of coronary artery disease (CAD) in type 1 diabetic patients with chronic renal failure undergoing hemodialysis.</p>
      <p><bold>METHODS:</bold> This is a descriptive study of 20 patients with type 1 <italic>diabetes mellitus</italic> undergoing hemodialysis without known CAD. CAD was assessed by quantitative coronary angiography (QCA) and intravascular ultrasound (IVUS). QCA was performed in all lesions <underline>&gt;</underline>30%, visually. All proximal 18-mm segments of the coronary arteries were analyzed by IVUS. All other coronary segments with stenosis <underline>&gt;</underline>30% were also analyzed.</p>
      <p><bold>RESULTS:</bold> Angiography detected 29 lesions <underline>&gt;</underline>30% in 15 patients (75%). Eleven (55%) of the lesions were <underline>&gt;</underline>50% and 10 (50%) <underline>&gt;</underline>70%. Thirteen patients had all 3 major arteries interrogated by IVUS. Atherosclerosis was present in all patients and in all 51 proximal 18-mm segments analyzed. The mean vessel diameter of these segments was significantly larger at the IVUS than at the QCA, for all vessels. IVUS images of 25 (86.2%) of the 29 lesions <underline>&gt;</underline>30% were obtained. Fibrotic plaques were common (48%) and 60% had intermediate vessel remodeling.</p>
      <p><bold>CONCLUSION:</bold> CAD was present in all vessels of all type 1 diabetic patients undergoing hemodialysis. These findings are in agreement with other autopsy, angiography and IVUS studies. Additionally, they indicate the need for additional epidemiological and imaging studies to better understand and treat such a complex and serious clinical condition affecting young people.</p>
      <p><bold>Key words:</bold> Coronary artery disease; <italic>diabetes mellitus</italic>, type 1; ultrasonography, interventional; renal insufficiency, chronic.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>In patients with type 1 <italic>diabetes mellitus</italic>, atherosclerosis occurs earlier in life and coronary artery disease (CAD) constitutes the major cause of death<sup>1</sup>. By the age of 55 years, the cumulative mortality rate due to CAD has been reported to be 30 to 40%<sup>2</sup>, which is much higher than the overall mortality rate of 4% in non-diabetic subjects. In fact, in type 1 diabetic patients, the mortality risk by CAD is increased 4 to 9 fold in men and 4 to 29 fold in women<sup>3</sup>. This risk is even higher when proteinuria or renal failure is present<sup>4,5</sup>. Tuomilehto et al<sup>6</sup> followed 5,148 type 1 diabetic patients for more than 10 years and found that once chronic renal failure occurs, CAD develops earlier and much more often<sup>6</sup>.</p>
      <p>Despite growing epidemiological and clinical interest, very few studies have been currently undertaken to characterize CAD in these individuals<sup>7-11</sup>, in opposition to type 2 diabetic patients. The present study was designed to evaluate the prevalence, the qualitative and quantitative characteristics of CAD in type 1 diabetic patients with chronic renal failure undergoing hemodialysis.</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>Patients with type 1 <italic>diabetes mellitus</italic> undergoing hemodialysis without known CAD were prospectively included in this descriptive and observational study. All patients underwent biochemical and standard hematological work-up. Cardiovascular assessment included electrocardiogram, Doppler-echocardiogram and an ischemic test.</p>
      <p>The study protocol was approved by the Ethics Committee of the Federal University of Sao Paulo and written informed consent was obtained from all participants.</p>
      <p>
        <bold>Quantitative coronary angiography and intravascular ultrasound analysis</bold>
      </p>
      <p>Nitroglycerin (300 &#181;g) was given immediately before angiograms and intravascular ultrasound (IVUS) interrogations.</p>
      <p>Visual analysis of coronary angiograms was performed by two experienced angiographists. Percent diameter stenosis of lesions was estimated and patients were classified as having normal arteries, lesions &lt; 30% or lesions <underline>&gt;</underline> 30%. Quantitative coronary angiography (QCA) was performed in all lesions <underline>&gt;</underline> 30% using an automated edge detection algorithm (QCA CMS System, MEDIS Medical Imaging Systems, Leiden, Netherlands). Lesion length, minimal <italic>lumen</italic> diameter, reference diameter and percent diameter stenosis were measured at these sites.</p>
      <p>IVUS imaging was performed using mechanical systems (Clear View or Galaxy, Boston Scientific, Sunnyvale, CA, USA) consisting of 30-MHz ultrasound catheters with a 0.5 mm/s motorized pull-back system. IVUS recording was initiated at the most distal segment of each vessel with diameter greater than 2 mm. Accordingly, at least half of the total vessel length was studied. The S-VHS recorded tape was used for offline measurements using dedicated IVUS analysis software (QIVA, Pie Medical, Netherlands). For this analysis, the most proximal 18-mm segment of the major coronary arteries was arbitrarily selected. Additionally, all other segments in the coronary tree presenting stenosis <underline>&gt;</underline> 30% at the angiography were analyzed.</p>
      <p>The following measurements were performed at the proximal 18-mm coronary segments: vessel, <italic>lumen</italic> and plaque cross-sectional areas (CSA) and maximum plaque thickness, at every millimeter<sup>12</sup>. Based on these measurements, vessel, <italic>lumen</italic> and plaque volumes were calculated. Minimal <italic>lumen</italic> CSA was also obtained. Atherosclerotic plaques were considered present when intimal thickness exceeded 0.3 mm<sup>13</sup>. The axial distribution of the plaque along each of these coronary segments was assessed by calculating its coefficient of variation, by dividing the mean plaque CSA by the standard deviation of the plaque CSA.</p>
      <p>At the segments selected for analysis for the presence of stenosis <underline>&gt;</underline> 30%, the <italic>lumen</italic>, vessel and plaque CSA were measured at the site with the minimum <italic>lumen</italic> CSA. Plaque burden was calculated as: (plaque CSA, / vessel CSA at the lesion site) x 100. Proximal and distal reference sites were defined as those cross-sections with the least amount of disease and largest <italic>lumen</italic> within 10 mm of the lesion boundary. At these sites, vessel and <italic>lumen</italic> CSA were measured. The averaged <italic>lumen</italic> CSA of the proximal and distal references was considered the reference <italic>lumen</italic> CSA. The <italic>lumen</italic> area stenosis was calculated as: [(reference <italic>lumen</italic> CSA minus <italic>lumen</italic> CSA at the lesion site / reference <italic>lumen</italic> CSA) x 100]. Vessel remodeling was determined based on the following definition: adaptive remodeling was considered to be present when vessel CSA at the lesion site was larger than vessel CSA at the proximal reference; constrictive remodeling was considered to be present when vessel CSA at the lesion site was smaller than vessel CSA at the distal reference and intermediate remodeling was present when vessel CSA at the lesion site was intermediate between vessel CSA at the proximal and distal references<sup>14</sup>. A remodeling index was calculated as vessel CSA at the lesion site divided by vessel CSA at the proximal reference<sup>15</sup>.</p>
      <p>At the lesion site, plaque composition was classified as soft, fibrotic or fibrocalcific, according to its characteristics<sup>12</sup>. QCA and IVUS measurements were performed at the Core Laboratory of Hospital Israelita Albert Einstein (S&#227;o Paulo, Brazil).</p>
      <p>
        <bold>Statistical analysis</bold>
      </p>
      <p>Quantitative data are presented as the mean value &#177; SD and qualitative data are presented as frequencies.</p>
      <p>To study the association of the presence of stenosis <underline>&gt;</underline> 30% with age and duration of type 1 diabetes, the Student's t test was applied. The same test was used to compare mean vessel diameter of the proximal 18-mm at the IVUS and angiography.</p>
      <p>The search for an association between plaque maximum thickness and plaque volume in the most proximal 18-mm segments of the coronary arteries and age, serum cholesterol, body mass index, hemodialysis duration, and diabetes duration was carried out by calculating Pearson's linear correlation coefficient.</p>
      <p>All significance tests were two-tailed, and <italic>p</italic> values &lt; 0.05 were considered significant.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>
        <bold>Study population</bold>
      </p>
      <p>From February to November 2003, 20 patients were recruited for the study. Demographic and clinical data are depicted in <xref ref-type="table" rid="t1-body2">Table 1</xref>. Only two patients (10%) presented myocardial ischemia at the functional tests.</p>
      <table-wrap id="t1-body2">
        <graphic xlink:href="1678-4170-abc-93-01-0015-00004-gt01-en.jpg"/></table-wrap>
      <p>
        <bold>Angiographic analysis</bold>
      </p>
      <p>Visual assessment of the coronary angiograms detected 29 lesions <underline>&gt;</underline> 30% in 15 (75%) patients [1.93 &#177; 1.03 lesions per patient (<xref ref-type="table" rid="t2-body2">Table 2</xref>)]. Eleven (55%) of them had lesions <underline>&gt;</underline> 50% and 10 (50%) had lesions <underline>&gt;</underline> 70%. One patient presented a proximal left anterior descending (LAD) artery occlusion. One of the patients with a positive ischemic test had stenosis in all three vessels [LAD: 50%, left circumflex (LCX): 80% and right coronary artery (RCA): 40%]. The other one presented stenosis in two vessels (LAD: 70% and RCA: 50%).</p>
      <table-wrap id="t2-body2">
        <graphic xlink:href="1678-4170-abc-93-01-0015-00004-gt02-en.jpg"/></table-wrap>
      <p>
        <bold>Intravascular ultrasound analysis</bold>
      </p>
      <p>IVUS imaging of the most proximal 18-mm segments of at least one of the major coronary arteries was obtained from all patients. Thirteen patients had all 3 major arteries interrogated, 5 patients had 2 and 2 patients had only one. Atherosclerosis was present in all patients and in all 51 most proximal 18-mm segments analyzed (18 LAD, 18 LCX and 15 RCA). These segments presented abundant and diffusely distributed atherosclerosis (<xref ref-type="fig" rid="f1-body2">Fig. 1</xref>). In 9 (17.6%) segments, minimal <italic>lumen</italic> CSA was <underline>&lt;</underline> 4 mm<sup>2</sup>. Plaque volume, maximum plaque thickness, minimal <italic>lumen</italic> CSA, and axial coefficient of variation of the plaque area for these segments are shown in <xref ref-type="table" rid="t3-body2">Table 3</xref>.</p>
      <table-wrap id="t3-body2">
        <graphic xlink:href="1678-4170-abc-93-01-0015-00004-gt03-en.jpg"/></table-wrap>
      <fig id="f1-body2">
        <graphic xlink:href="1678-4170-abc-93-01-0015-00004-gf01-en.jpg"/></fig>
      <p>The mean vessel diameter of the proximal segments was significantly larger at the IVUS than at the QCA, in all vessels: [18 LAD segments: 4.24 &#177; 0.45 vs. 3.30 &#177; 0.59 (p&lt;0.001)]; [18 LCX segments: 3.64 &#177; 0.60 vs. 3.20 &#177; 0.56 (p=0.02)]; [15 RCA segments: 4.35 &#177; 0.56 vs. 3.82 &#177; 0.56 (p=0.01)].</p>
      <p>IVUS images of 25 (86.2%) of the 29 lesions <underline>&gt;</underline> 30% were obtained. Fibrotic plaques were the most common (48%) and the majority presented intermediate vessel remodeling (60%). Plaque characteristics, plaque burden, <italic>lumen</italic> area stenosis and minimal <italic>lumen</italic> CSA of these lesions are shown in <xref ref-type="table" rid="t3-body2">Table 3</xref>.</p>
      <p>Age and diabetes duration were related to greater plaque thickness, plaque volume and the presence of lesions <underline>&gt;</underline> 30% (<xref ref-type="fig" rid="en04f02-body2">Fig. 2</xref>).</p>
      <p content-type="asset">
        <fig id="en04f02-body2">
          <graphic xlink:href="1678-4170-abc-93-01-0015-00004-gf02-en.jpg"/></fig>
      </p>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>The most remarkable finding of this study was the diffuse vessel involvement and the large amount of atherosclerosis identified at the IVUS in this selected population of type 1 diabetic patients with end-stage renal disease (ESRD). We verified a relatively uniform plaque distribution along all the most proximal 18-mm segments, as shown by the low plaque area axial coefficient of variation (33.6 &#177; 10%). Additionally, plaque quantification in these segments demonstrated the existence of large plaque masses by both the axially corrected plaque volume (4.6 &#177; 2.4 mm<sup>3</sup>/mm) and maximum intimal thickness (1.49 &#177; 0.71 mm).</p>
      <p>The development of atherothrombosis in the presence of nephropathy has been attributed to several mechanisms, including hypertension, dyslipidemia, and abnormalities of fibrinolysis and coagulation. Diabetic nephropathy is associated with an atherogenic lipoprotein profile, including elevated low-density lipoprotein, very low-density lipoprotein, and lipoprotein (a) and decreased high-density lipoprotein. Furthermore, a hypercoagulable state, characterized by increased plasminogen activator inhibitor-I, factor VII and plasma fibrinogen levels has been described. Reduced renal function can lead to the accumulation of advanced glycosylation end-products in the circulation and tissues, which may accelerate atherosclerosis<sup>16</sup>.</p>
      <p>Based on the angiographic parameters, the high prevalence of significant lesions replicated the findings we had previously reported in type 1 diabetic patients who underwent angiography for CAD screening before simultaneous pancreas-kidney transplantation<sup>8</sup>.</p>
      <p>The amount and extent of atherosclerosis found at the IVUS in our investigation are in agreement with the results reported in a necropsy study of 9 individuals with average age of 29 years at the time of death<sup>17</sup>. In this study, 90.5 cm (47%) of the total 191 cm of coronary artery segments assessed had more than 50% of cross-sectional area stenosis, compared with only 2 cm of the 155 cm in the control group of similar age and sex. Another coronary IVUS study in type 1 diabetes also reported that all patients had CAD<sup>11</sup>. Interestingly, these results were obtained in a less sick population when compared to ours, because individuals with creatinine &gt; 150 &#181;mol/l and overt nephropathy (urinary albumin excretion &gt; 300 mg/24 h) were excluded.</p>
      <p>Larsen et al<sup>18</sup> showed that the degree of subclinical coronary atherosclerosis was significantly more severe in patients with type 1 diabetes than in controls. The mean plaque area (by IVUS) was <underline>&gt;</underline> 40% in 71% of diabetic arteries when compared to 33% of control arteries (p &lt; 0.001).</p>
      <p>Importantly, our study showed the predominance of atherosclerotic lesions with characteristics of stability, represented by their fibrotic composition with negative or intermediate remodeling. However, even considering the lower percentage of potentially vulnerable plaques (lipidic composition with positive remodeling), the enormous amount of disease makes it a frequent finding in the coronary tree of type 1 diabetic patients with ESRD, which may explain the high rates of adverse events in this population.</p>
      <p>When correlating clinical variables with coronary atherosclerosis, we observed that age and diabetes duration were related to greater plaque thickness, plaque volume and the presence of lesions <underline>&gt;</underline> 30%. We did not find any correlation between coronary atherosclerosis and serum cholesterol, smoking, body mass index, and the hemodialysis procedure. For a few of these variables, the lack of correlation might be due to beta error. In another study<sup>19</sup>, a 1% increase in mean HbA<sub>1c</sub> over 18 years implied in a 6.4% increase in plaque burden, 15 mg increase in total cholesterol implied in 10% increase in plaque burden and a 10-year increase in age implied in a 16.2% increase in plaque burden.</p>
      <p>It is known that the angiography underestimates vessel diameter and atherosclerosis extent when compared with IVUS, and there are three predictors for this discrepancy: vessel diameter by angiography &lt; 3 mm, proximal segments and diabetes, presumably type 2. Our study is the first to address this issue in type 1 diabetic patients<sup>20</sup>.</p>
      <p>Magnetic resonance imaging and computed tomography (through the evaluation of coronary artery calcium content) can identify subclinical CAD<sup>16, 21</sup>. The calcium score has been used to evaluate the prevalence and prognosis of CAD in type 1 diabetic patients<sup>22,23</sup>. However, in patients with ESRD, the association between coronary calcium and coronary atherosclerosis is less well established<sup>24</sup>.</p>
      <p>Currently, a better CAD characterization in type 1 diabetic patients with ESRD undergoing hemodialysis has become more important, in view of the increasingly availability of simultaneous pancreas-kidney transplantation. This modern treatment may improve cardiovascular outcome in these patients. In fact, it has been reported that CAD progression is reduced based on the results of angiography performed before transplantation and four years later<sup>25</sup>.</p>
      <p>This study has two main limitations: the small sample size, and the lack of information regarding long-term glycemic control.</p>
      <p>
        <bold>Conclusion</bold>
      </p>
      <p>In summary, subclinical CAD is present in all vessels of all type 1 diabetic patients undergoing hemodialysis. It indicates the need for additional epidemiological and imaging studies to better understand and treat such a complex and serious clinical condition affecting young people.</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>There were no external funding sources for this study.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the thesis of doctoral submitted by Dinaldo Cavalcanti de Oliveira, from Universidade Federal de S&#227;o Paulo.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories/>
      <title-group>
        <article-title xml:lang="es">Enfermedad arterial coronaria subcl&#237;nica en pacientes con Diabetes Mellitus tipo 1 en hemodi&#225;lisis</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>FUNDAMENTO: La aterosclerosis ocurre m&#225;s temprano en pacientes con diabetes mellitus tipo 1 (DM-1) y la enfermedad arterial coronaria (EAC) constituye la m&#225;s importante causa de muerte. OBJETIVO: Evaluar la prevalencia y las caracter&#237;sticas anat&#243;micas de la EAC en pacientes con DM-1 e insuficiencia renal cr&#243;nica, sometidos a di&#225;lisis. M&#201;TODOS: Este es un estudio descriptivo de 20 pacientes con DM-1 sometidos a di&#225;lisis sin EAC conocida. La EAC se evalu&#243; mediante angiograf&#237;a coronaria cuantitativa (ACC) y ultrasonido intravascular (IVUS). La ACC se realiz&#243; en todas las lesiones &gt;30%, se llev&#243; a cabo el an&#225;lisis visual por IVUS en todos los segmentos proximales de 18 mm de las arterias coronarias. Tambi&#233;n se analizaron todos los otros segmentos coronarios con estenosis &gt;30%. RESULTADOS: La angiograf&#237;a detect&#243; 29 lesiones &gt;30% en 15 pacientes (75%). Once (55%) de las lesiones eran &gt;50% y 10 (50%) &gt;70%. Trece pacientes tuvieron las tres arterias principales evaluadas por el IVUS. La aterosclerosis estaba presente en todos los pacientes y en todos los 51 segmentos proximales de 18 mm analizados. Esos segmentos significan que la medici&#243;n del di&#225;metro de los vasos resultaba significantemente mayor en el IVUS que en la ACC, en todos los vasos. De las im&#225;genes del IVUS se obtuvieron 25 (86,2%) de las 29 lesiones &gt;30%. Placas fibr&#243;ticas eran comunes (48%) y el 60% presentaban remodelamiento intermediario de vasos. CONCLUSI&#211;N: La EAC estaba presente en todos los vasos de todos los pacientes con diabetes tipo 1 sometidos a hemodi&#225;lisis. Esos hallazgos est&#225;n de acuerdo con otros estudios de autopsia, angiograf&#237;a e IVUS. Adem&#225;s de ello, indican la necesidad de estudios adicionales epidemiol&#243;gicos y de imagen, para una mejor comprensi&#243;n y tratamiento de una condici&#243;n cl&#237;nica compleja y severa que afecta a j&#243;venes individuos.</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>Enfermedad coronaria</kwd>
        <kwd>diabetes mellitus tipo 1</kwd>
        <kwd>insuficiencia renal cr&#243;nica</kwd>
        <kwd>ultrasonido de intervenci&#243;n</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO ORIGINAL</bold>
      </p>
      <p>
        <fn id="top-body3">
          <label>
            <bold>Enfermedad arterial coronaria subcl&#237;nica en pacientes con <italic>Diabetes Mellitus</italic> tipo 1 en hemodi&#225;lisis</bold>
          </label>
          <p>
            <bold>Dinaldo Cavalcanti de Oliveira<sup>I, II</sup>; Fabio Sandoli de Brito Junior<sup>I, II</sup>, Rosley Weber Alvarenga Fernandes<sup>I, II</sup>, Jo&#227;o Roberto de Sa<sup>I,II</sup>; Valter Correia de Lima<sup>I, II</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Hospital do Rim e Hipertens&#227;o - Funda&#231;&#227;o Oswaldo Ramos, S&#227;o Paulo, SP - Brasil</p>
      <p><sup>II</sup>Hospital S&#227;o Paulo - Universidade Federal de S&#227;o Paulo, S&#227;o Paulo, SP - Brasil</p>
      <p>Correspondencia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p><bold>FUNDAMENTO:</bold> La aterosclerosis ocurre m&#225;s temprano en pacientes con diabetes mellitus tipo 1 (DM-1) y la enfermedad arterial coronaria (EAC) constituye la m&#225;s importante causa de muerte.</p>
      <p><bold>OBJETIVO:</bold> Evaluar la prevalencia y las caracter&#237;sticas anat&#243;micas de la EAC en pacientes con DM-1 e insuficiencia renal cr&#243;nica, sometidos a di&#225;lisis.</p>
      <p><bold>M&#201;TODOS:</bold> Este es un estudio descriptivo de 20 pacientes con DM-1 sometidos a di&#225;lisis sin EAC conocida. La EAC se evalu&#243; mediante angiograf&#237;a coronaria cuantitativa (ACC) y ultrasonido intravascular (IVUS). La ACC se realiz&#243; en todas las lesiones <underline>&gt;</underline>30%, se llev&#243; a cabo el an&#225;lisis visual por IVUS en todos los segmentos proximales de 18 mm de las arterias coronarias. Tambi&#233;n se analizaron todos los otros segmentos coronarios con estenosis <underline>&gt;</underline>30%.</p>
      <p><bold>RESULTADOS:</bold> La angiograf&#237;a detect&#243; 29 lesiones <underline>&gt;</underline>30% en 15 pacientes (75%). Once (55%) de las lesiones eran <underline>&gt;</underline>50% y 10 (50%) <underline>&gt;</underline>70%. Trece pacientes tuvieron las tres arterias principales evaluadas por el IVUS. La aterosclerosis estaba presente en todos los pacientes y en todos los 51 segmentos proximales de 18 mm analizados. Esos segmentos significan que la medici&#243;n del di&#225;metro de los vasos resultaba significantemente mayor en el IVUS que en la ACC, en todos los vasos. De las im&#225;genes del IVUS se obtuvieron 25 (86,2%) de las 29 lesiones <underline>&gt;</underline>30%. Placas fibr&#243;ticas eran comunes (48%) y el 60% presentaban remodelamiento intermediario de vasos.</p>
      <p><bold>CONCLUSI&#211;N:</bold> La EAC estaba presente en todos los vasos de todos los pacientes con diabetes tipo 1 sometidos a hemodi&#225;lisis. Esos hallazgos est&#225;n de acuerdo con otros estudios de autopsia, angiograf&#237;a e IVUS. Adem&#225;s de ello, indican la necesidad de estudios adicionales epidemiol&#243;gicos y de imagen, para una mejor comprensi&#243;n y tratamiento de una condici&#243;n cl&#237;nica compleja y severa que afecta a j&#243;venes individuos. </p>
      <p><bold>Palabras clave: </bold> Enfermedad coronaria, diabetes mellitus tipo 1, insuficiencia renal cr&#243;nica, ultrasonido de intervenci&#243;n.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>En pacientes con <italic>diabetes mellitus</italic> tipo 1 (DM1), la aterosclerosis ocurre m&#225;s temprano y la enfermedad arterial coronaria (EAC) es la mayor causa de muerte<sup>1</sup>. Alrededor de los 55 a&#241;os de edad, se ha relatado una tasa de mortalidad acumulativa en raz&#243;n de la EAC del 30% al 40%<sup>2</sup>, que es bien m&#225;s alta que la tasa de mortalidad general, que es del 4% en individuos no diab&#233;ticos. De hecho, en pacientes con DM1, el riesgo de mortalidad por EAC aumenta de 4 a 9 veces en varones y 4 a 29 veces en mujeres<sup>3</sup>. Ese riesgo es todav&#237;a mayor cuando la proteinuria o insuficiencia renal est&#225; presente<sup>4,5</sup>. Tuomilehto et al.<sup>6</sup> siguieron a 5.148 pacientes con DM1 por m&#225;s de 10 a&#241;os y descubrieron que cuando la insuficiencia renal cr&#243;nica se manifiesta, la EAC se desarrolla m&#225;s temprano y mucho m&#225;s frecuentemente<sup>6</sup>.</p>
      <p>No obstante del creciente inter&#233;s epidemiol&#243;gico y cl&#237;nico, pocos estudios contempor&#225;neos han sido realizados para caracterizar la EAC en esos individuos<sup>711</sup>, en oposici&#243;n a los pacientes con <italic>diabetes mellitus</italic> tipo 2.</p>
      <p>El presente estudio tuvo por objeto evaluar la prevalencia y las caracter&#237;sticas cualitativas y cuantitativas de la EAC en pacientes con DM1 con insuficiencia renal cr&#243;nica, sometidos a hemodi&#225;lisis.</p>
      <p>
        <bold>M&#233;todos</bold>
      </p>
      <p>Pacientes con DM1 sometidos a hemodi&#225;lisis sin EAC conocida fueron prospectivamente incluidos en ese estudio observacional y descriptivo. Todos los pacientes fueron sometidos a ex&#225;menes bioqu&#237;micos y hematol&#243;gicos est&#225;ndar. La evaluaci&#243;n cardiol&#243;gica incluy&#243; electrocardiograma, ecocardiograma Doppler y prueba isqu&#233;mica.</p>
      <p>El Comit&#233; de &#201;tica de la Universidad Federal de S&#227;o Paulo aprob&#243; el protocolo del estudio y todos los participantes firmaron el formulario de consentimiento informado.</p>
      <p>
        <bold>Angiograf&#237;a coronaria cuantitativa y an&#225;lisis de ultrasonido intravascular</bold>
      </p>
      <p>Nitroglicerina (300 &#181;g) se administr&#243; inmediatamente antes de los angiogramas y evaluaciones por ultrasonido intravascular (IVUS). Dos angiografistas experimentados llevaron a cabo el an&#225;lisis visual de los angiogramas coronarios. Se estim&#243; el porcentaje del di&#225;metro de la estenosis de las lesiones. A los pacientes se les clasificaron de acuerdo con el porcentaje de las lesiones: arterias normales, lesiones &lt; 30% o lesiones <underline>&gt;</underline> 30%. La angiograf&#237;a coronaria cuantitativa (ACC) se realiz&#243; en todas las lesiones <underline>&gt;</underline> 30%, con el empleo de un algoritmo de detecci&#243;n de borde automatizado <italic>(QCA CMS System, MEDIS Medical Imaging Systems, Leiden,</italic> Pa&#237;ses Bajos). Se midieron en esos locales la largura de la lesi&#243;n, el di&#225;metro m&#237;nimo del lumen, el di&#225;metro de referencia y porcentaje del di&#225;metro de la estenosis.</p>
      <p>El estudio de imagen por IVUS se realiz&#243; a trav&#233;s de sistemas mec&#225;nicos (Clear View o Galaxy, Boston Scientific, Sunnyvale, CA, EUA) con cat&#233;ter de ultrasonido de 30 MHz con un sistema de retirada <italic>(pullback)</italic> motorizado de 0,5 mm/s. El registro del IVUS se inici&#243; en el segmento m&#225;s distal de cada vaso con di&#225;metro mayor que 2 mm. De manera adecuada, se estudi&#243; la mitad de la largura total de los vasos como m&#237;nimo. La grabaci&#243;n de la cinta S-VHS se emple&#243; para el c&#225;lculo fuera de l&#237;nea con la utilizaci&#243;n de un <italic>software</italic> de an&#225;lisis dedicado para IVUS (QIVA, Pie Medical, Pa&#237;ses Bajos). Para ese an&#225;lisis, el segmento de 18 mm m&#225;s proximal de las principales arterias coronarias fue arbitrariamente seleccionado. Adem&#225;s de ello, se analizaron todos los otros segmentos en el &#225;rbol coronario que presentaban estenosis <underline>&gt;</underline> 30% en la angiograf&#237;a.</p>
      <p>Se llevaron a cabo las mediciones que siguen a continuaci&#243;n, en los segmentos coronarios de 18 mm proximales: &#225;reas transversales (AT) del vaso, lumen y placa y m&#225;ximo grosor de la placa, a cada mil&#237;metro<sup>12</sup>. Con base en esos valores, se calcularon los vol&#250;menes del vaso, lumen y placa. La AT m&#237;nima del lumen tambi&#233;n se obtuvo. Se tuvieron en cuenta las placas ateroscler&#243;ticas presentes cuando el grosor de la &#237;ntima exced&#237;a 0,3 mm<sup>13</sup>. La distribuci&#243;n axial de la placa a lo largo de cada uno de esos segmentos coronarios se evalu&#243; mediante el c&#225;lculo de su coeficiente de variaci&#243;n, dividiendo la AT promedio de la placa por la desviaci&#243;n-est&#225;ndar de la AT de la placa.</p>
      <p>En los segmentos seleccionados para an&#225;lisis de la presencia de estenosis <underline>&gt;</underline> 30%, la AT del lumen, vaso y placa se midi&#243; en el local con la AT m&#237;nima del lumen. El grado de compromiso se calcul&#243; como: (AT placa/AT vaso en el local de la lesi&#243;n) x 100. Las l&#237;neas de referencia distal y proximal se definieron como las &#225;reas transversales con la menor cantidad de la enfermedad y el mayor lumen dentro de un l&#237;mite de 10 mm de la lesi&#243;n. En esos segmentos, se midi&#243; la AT del vaso y del lumen. El promedio de la AT del lumen de las referencias distal y proximal se consider&#243; como la AT de referencia del lumen. La estenosis del &#225;rea del lumen se calcul&#243; como: [(AT de referencia del lumen menos AT del lumen en el segmento de la lesi&#243;n / AT de referencia del lumen<italic>)</italic> x 100]. El remodelamiento del vaso se determin&#243; basado en la siguiente definici&#243;n: el remodelamiento adaptativo se consider&#243; como presente cuando la AT del vaso en el local de la lesi&#243;n era mayor que la AT del vaso en la referencia proximal; el remodelamiento constrictivo se consider&#243; como presente cuando la AT del vaso en el segmento de la lesi&#243;n era menor que la AT del vaso en la referencia distal y el remodelamiento intermediario estaba presente cuando la AT del vaso en el segmento de la lesi&#243;n era intermediario entre la AT del vaso en las referencias distal y proximal<sup>14</sup>. Un &#237;ndice de remodelamiento se calcul&#243; como AT del vaso en el segmento de la lesi&#243;n dividido por la AT del vaso en la referencia proximal<sup>15</sup>. En el segmento de la lesi&#243;n, la composici&#243;n de la placa se la clasific&#243; como blanda, fibr&#243;tica o fibrocalcificada, de acuerdo con sus caracter&#237;sticas<sup>12</sup>. Las mediciones por ACC e IVUS se realizaron en el laboratorio central del Hospital Israelita Albert Einstein (S&#227;o Paulo, Brasil).</p>
      <p>
        <bold>An&#225;lisis estad&#237;stico</bold>
      </p>
      <p>Datos cuantitativos se presentaron como el valor promedio &#177; DE y los datos cualitativos se presentaron como frecuencias.</p>
      <p>Para estudiar la asociaci&#243;n entre la presencia de estenosis <underline>&gt;</underline> 30%, edad y DM1, se aplic&#243; la prueba <italic>t</italic> de Student. La misma prueba se emple&#243; para comparar el di&#225;metro promedio del vaso de los 18 mm proximales por el IVUS y la angiograf&#237;a.</p>
      <p>La b&#250;squeda por una asociaci&#243;n entre el grosor m&#225;ximo de la placa y el volumen de la placa en los 18 mm m&#225;s proximales de las arterias coronarias y edad, colesterol s&#233;rico, &#237;ndice de masa corporal, duraci&#243;n de la hemodi&#225;lisis y duraci&#243;n de la diabetes se llev&#243; a cabo a trav&#233;s del c&#225;lculo del coeficiente de correlaci&#243;n lineal de Pearson. Todas las pruebas de significancia fueron de dos colas y los valores de p&lt; 0,05 se los consideraron como significantes.</p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>
        <bold>Poblaci&#243;n del estudio</bold>
      </p>
      <p>De febrero a noviembre de 2003, se reclutaron a 20 pacientes. Las caracter&#237;sticas demogr&#225;ficas y cl&#237;nicas est&#225;n presentadas en la <xref ref-type="table" rid="t1-body3">Tabla 1</xref>. Solamente dos pacientes (10%) presentaron isquemia mioc&#225;rdica en las pruebas funcionales.</p>
      <table-wrap id="t1-body3">
        <graphic xlink:href="1678-4170-abc-93-01-0015-00004-gt01-es.jpg"/></table-wrap>
      <p>
        <bold>An&#225;lisis angiogr&#225;fico</bold>
      </p>
      <p>Por medio de la evaluaci&#243;n visual de los angiogramas coronarios se pudo detectar 29 lesiones <underline>&gt;</underline> 30% en 15 (75%) pacientes [1,93 &#177; 1,03 lesiones por paciente (<xref ref-type="table" rid="t2-body3">Tabla 2</xref>)]. Once (55%) de ellos presentaban lesiones <underline>&gt;</underline> 50% y 10 (50%) lesiones <underline>&gt;</underline> 70%. Un paciente presentaba oclusi&#243;n proximal de la arteria descendente anterior izquierda (ADI). Uno de los pacientes con prueba isqu&#233;mica positiva presentaba estenosis en todos los tres vasos [ADI: 50%, circunfleja izquierda (CI): 80% y arteria coronaria derecha (ACD): 40%]. El otro presentaba estenosis en dos vasos (ADI: 70% y ACD: 50%).</p>
      <table-wrap id="t2-body3">
        <graphic xlink:href="1678-4170-abc-93-01-0015-00004-gt02-es.jpg"/></table-wrap>
      <p>
        <bold>An&#225;lisis por ultrasonido intravascular</bold>
      </p>
      <p>Se obtuvieron de los pacientes im&#225;genes por IVUS del segmento de 18 mm m&#225;s proximal de al menos una de las grandes arterias coronarias. Trece pacientes tuvieron las tres principales arterias evaluadas; 5 pacientes tuvieron 2 y 2 pacientes tuvieron solamente una arteria principal evaluada. La aterosclerosis estaba presente en todos los pacientes y en todos los 51 segmentos proximales de 18 mm analizados (18 ADI, 18 CI y 15 ACD). En esos segmentos, hab&#237;a una gran cantidad de aterosclerosis, con distribuci&#243;n difusa (<xref ref-type="fig" rid="es04f01-body3">Fig. 1</xref>). En 9 (17,6%) segmentos, la AT m&#237;nima del lumen fue <underline>&lt;</underline> 4 mm<sup>2</sup>. El volumen de la placa, m&#225;xima grosor de la placa, AT m&#237;nima del lumen y coeficiente de variaci&#243;n axial del &#225;rea de la placa para esos segmentos est&#225;n detallados en la <xref ref-type="table" rid="t3-body3">Tabla 3</xref>. El valor promedio del di&#225;metro del vaso de los segmentos proximales era significantemente mayor en el IVUS que en la ACC, en todos los vasos: [18 segmentos ADI: 4,24 &#177; 0,45 vs. 3,30 &#177; 0,59 (p&lt;0,001)]; [18 segmentos CI: 3,64 &#177; 0,60 vs. 3.20 &#177; 0.56 (p = 0.02)]; [15 segmentos ACD: 4,35 &#177; 0,56 vs. 3,82 &#177; 0,56 (p=0,01)]. Se obtuvieron las im&#225;genes por IVUS de 25 (86,2%) de las 29 lesiones <underline>&gt;</underline> 30%. Placas fibr&#243;ticas eran m&#225;s comunes (48%) y la mayor&#237;a presentaba remodelamiento intermediario de vasos (60%). Las caracter&#237;sticas de la placa, grado de compromiso, estenosis del &#225;rea del lumen y AT m&#237;nima del lumen de esas lesiones est&#225;n presentadas en la <xref ref-type="table" rid="t3-body3">Tabla 3</xref>.</p>
      <p content-type="asset">
        <fig id="es04f01-body3">
          <graphic xlink:href="1678-4170-abc-93-01-0015-00004-gf01-es.jpg"/></fig>
      </p>
      <table-wrap id="t3-body3">
        <graphic xlink:href="1678-4170-abc-93-01-0015-00004-gt03-es.jpg"/></table-wrap>
      <p>La edad y la duraci&#243;n de la <italic>diabetes mellitus</italic> estaban relacionadas con mayor grosor de placa, volumen de placa y la presencia de lesiones <underline>&gt;</underline> 30% (<xref ref-type="fig" rid="es04f02-body3">Fig. 2</xref>).</p>
      <p content-type="asset">
        <fig id="es04f02-body3">
          <graphic xlink:href="1678-4170-abc-93-01-0015-00004-gf02-es.jpg"/></fig>
      </p>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>El hallazgo m&#225;s importante de ese estudio fue la implicaci&#243;n difusa del vaso y la gran cantidad de aterosclerosis vista a trav&#233;s de las im&#225;genes del IVUS en esa poblaci&#243;n elegida con <italic>diabetes mellitus</italic> tipo 1 y enfermedad renal terminal (ERT). Verificamos una distribuci&#243;n relativamente uniforme de placa a lo largo de los segmentos de 18 mm m&#225;s proximales, como evidenciado por el bajo coeficiente de variaci&#243;n axial del &#225;rea de placa (33,6 &#177; 10%). Adicionalmente, la cuantificaci&#243;n de la placa en esos segmentos demostr&#243; la existencia de una gran masa de placa, a trav&#233;s del volumen de placa corregido axialmente (4,6 &#177; 2,4 mm<sup>3</sup>/mm) y por el m&#225;ximo grosor de la &#237;ntima (1,49 &#177; 0,71 mm).</p>
      <p>El desarrollo de aterotrombosis en la presencia de nefropat&#237;a ha sido atribuido a varios mecanismos, incluso hipertensi&#243;n, dislipidemia y anormalidades de fibrin&#243;lisis y coagulaci&#243;n. La nefropat&#237;a diab&#233;tica est&#225; asociada a un perfil aterog&#233;nico de lipoprote&#237;nas, incluso elevaci&#243;n de los niveles de lipoprote&#237;na de baja densidad, lipoprote&#237;na de muy baja densidad y lipoprote&#237;na y disminuci&#243;n de los niveles de lipoprote&#237;na de alta densidad. Adem&#225;s, han sido descritos un estado hipercoagulable -caracterizado por aumento del inhibidor del activador del plasmin&#243;geno-1- factor VIII y niveles de fibrin&#243;geno plasm&#225;tico. Funci&#243;n renal reducida puede llevar a la acumulaci&#243;n de productos avanzados de glicosilaci&#243;n en la circulaci&#243;n y en tejidos, lo que puede acelerar la aterosclerosis<sup>16</sup>.</p>
      <p>Teniendo en cuenta los par&#225;metros angiogr&#225;ficos, el alta prevalencia de lesiones significantes rechaz&#243; los hallazgos previamente relatados por nosotros en pacientes con diabetes tipo 1 sometidos a angiograf&#237;a para evaluaci&#243;n de EAC antes de transplante doble de p&#225;ncreas y ri&#241;&#243;n<sup>8</sup>.</p>
      <p>La cantidad y la extensi&#243;n de la aterosclerosis encontrada por IVUS en nuestra investigaci&#243;n est&#225;n de acuerdo con los resultados relatados en un estudio de necropsia de 9 individuos con edad promedio de 29 a&#241;os a la &#233;poca de la muerte<sup>17</sup>.</p>
      <p>En este estudio, 90,5 cm (47%) del total de 191 cm de segmento de arterias coronarias evaluadas presentaban m&#225;s de 50% de estenosis del &#225;rea transversal, comparados con solamente 2 cm del total de 155 cm del grupo control de mismo sexo y edad semejante. Otro estudio coronario con IVUS en diabetes tipo 1 tambi&#233;n relat&#243; que todos los pacientes ten&#237;an EAC<sup>11</sup>. Es interesante notar que esos resultados se obtuvieron en una poblaci&#243;n menos enferma, cuando comparada con la nuestra, porque a los individuos con creatinina &gt; 150 &#181;mol/l y nefropat&#237;a manifiesta (excreci&#243;n de alb&#250;mina urinaria &gt; 300 mg/24 h) se les excluyeron.</p>
      <p>Larsen et al.<sup>18</sup> revelaron que el grado de aterosclerosis coronaria subcl&#237;nica era significantemente m&#225;s severa en pacientes con diabetes tipo 1 que en los controles. El &#225;rea promedio de la placa (por IVUS) era <underline>&gt;</underline> 40% en el 71% de las arterias de los pacientes diab&#233;ticos cuando comparada con el 33% de las arterias de los controles (p &lt; 0,001).</p>
      <p>Es interesante notar que nuestro estudio evidenci&#243; la predominancia de las lesiones ateroscler&#243;ticas con caracter&#237;sticas de estabilidad, representadas por su composici&#243;n fibr&#243;tica con remodelamiento negativo o intermediario. Sin embargo, aun teniendo en cuenta el porcentaje m&#225;s bajo de placas potencialmente vulnerables (composici&#243;n lip&#237;dica con remodelamiento positivo), el gran volumen de la enfermedad hace con que se halle frecuente en el &#225;rbol coronario de pacientes con <italic>diabetes mellitus</italic> tipo 1 y DRT, lo que podr&#237;a explicar las altas tasas de eventos adversos en esa poblaci&#243;n.</p>
      <p>Al relacionarse las variables cl&#237;nicas con la aterosclerosis coronaria, descubrimos que la edad y la duraci&#243;n de la diabetes estaban relacionadas con el mayor grosor de la placa, volumen de la placa y la presencia de lesiones <underline>&gt;</underline> 30%. No encontramos ninguna correlaci&#243;n entre aterosclerosis coronaria y niveles s&#233;ricos de colesterol, fumo, &#237;ndice de masa corporal y el procedimiento de hemodi&#225;lisis. Para pocas de esas variables, la falta de correlaci&#243;n puede ser debido a error beta. En otro estudio<sup>19</sup>, un aumento de 1% en la HbA<sub>1c</sub> promedio durante 18 a&#241;os supuso un aumento de un 6,4% en el grado de compromiso de las coronarias, 15 mg de aumento en el colesterol total supuso el 10% de aumento en el grado de compromiso y un aumento de 10 a&#241;os en la edad supuso un aumento de un 16,2% en el grado de compromiso.</p>
      <p>Se sabe que la angiograf&#237;a subestima el di&#225;metro del vaso y la extensi&#243;n de la aterosclerosis, cuando comparada al IVUS y hay tres predictores para esa discrepancia: di&#225;metro del vaso por la angiograf&#237;a &lt; 3 mm, segmentos proximales y diabetes, presumidamente tipo 2. Nuestro estudio es el primer a abordar ese asunto en pacientes con diabetes tipo 1<sup>20</sup>.</p>
      <p>El estudio de imagen por resonancia magn&#233;tica y tomograf&#237;a computarizada (a trav&#233;s de la evaluaci&#243;n del contenido de calcio en la arteria coronaria) puede identificar EAC subcl&#237;nica<sup>16,21</sup>. El score de calcio ha sido utilizado para evaluar la prevalencia y el pron&#243;stico de la EAC en pacientes con diabetes tipo 1<sup>22,23</sup>. Sin embargo, en pacientes con DRT, la relaci&#243;n del calcio coronario con la aterosclerosis coronaria todav&#237;a no est&#225; bien aclarada<sup>24</sup>.</p>
      <p>Actualmente, una mejor caracterizaci&#243;n de la EAC en pacientes con diabetes tipo 1 con DRT sometidos a di&#225;lisis ha se convertido m&#225;s importante, teniendo en cuenta la creciente disponibilidad de transplantes dobles de p&#225;ncreas y ri&#241;&#243;n. Ese moderno tratamiento puede mejorar el resultado cardiovascular en esos pacientes. De hecho, ha sido relatado que la progresi&#243;n de la EAC es reducida, con base en los resultados de la angiograf&#237;a realizada antes del transplante y cuatro a&#241;os despu&#233;s<sup>25</sup>.</p>
      <p>El presente estudio tiene dos principales limitaciones: el n&#250;mero limitado de pacientes y la falta de informaciones sobre el control gluc&#233;mico de largo plazo.</p>
      <p>
        <bold>Conclusi&#243;n</bold>
      </p>
      <p>En resumen, la EAC subcl&#237;nica est&#225; presente en todos los vasos de todos los pacientes con <italic>diabetes mellitus</italic> tipo 1 sometidos a di&#225;lisis. Eso indica la necesidad de estudios adicionales epidemiol&#243;gicos y de imagen, para una mejor comprensi&#243;n y tratamiento de una condici&#243;n cl&#237;nica compleja y severa que afecta a j&#243;venes individuos.</p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiaci&#243;n</bold>
      </p>
      <p>El presente estudio no tuvo fuentes de financiaci&#243;n externas.</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>Este art&#237;culo forma parte de tesis de doctorado de Dinaldo Cavalcanti de Oliveira, por la Universidad Federal de S&#227;o Paulo.</p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
</article>
